An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 216334
Company: ANNORA PHARMA

Products on ANDA 216334

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MESALAMINE	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 216334

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/05/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 216334

MESALAMINE

TABLET, DELAYED RELEASE;ORAL; 1.2GM
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LIALDA	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	Yes	AB	022000	TAKEDA PHARMS USA
MESALAMINE	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	203817	ACTAVIS LABS FL
MESALAMINE	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	216334	ANNORA PHARMA
MESALAMINE	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	217337	SINOTHERAPEUTICS INC
MESALAMINE	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	211858	SUN PHARM
MESALAMINE	MESALAMINE	1.2GM	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	091640	ZYDUS PHARMS

Top